Antiplatelet Therapy

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with...

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers unique insight into the use, safety and effectiveness of blood thinners prasugrel and clopidogrel in hospitals across the United States. 

September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug-eluting stent (DES) implantation demonstrated that six weeks of drug therapy was not superior to six months of therapy with regard...

Xarelto, rivaroxaban, Starter Pack, FDA, deep vein thrombosis, pulmonary embolis
The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein thrombosis (DVT) and/or pulmonary embolism (PE) treatment. The...
Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death...
nanoparticles, stroke, tPA, blood clot, magnetic, MRI, antiplatelet
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to...
antiplatelet therapy, pharmaceuticals, cath lab, clinical trial, ticagrelor
AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more than 21,000 patients, successfully met its primary...
Xarelto, rivaroxaban, Starter Pack, FDA, deep vein thrombosis, pulmonary embolis
The Xarelto Starter Pack from Janssen Pharmaceuticals Inc. was designed to help simplify the dosing for the initial 30-day treatment period
The latest quantification metrics for ScImage's PicomSRI structured echocardiography reporting platform are based on guidelines published...
Precession from Heart Imaging Technologies is a cardiac magnetic resonance solution which allows viewing, analysis and reporting all within...
The newest version of the American College of Radiology (ACR) Appropriateness Criteria updated 19 appropriateness criteria topics and added...

Articles

rivaroxaban, Xarelto, safety performance, Janssen, NVAF
A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in patients with non-valvular atrial fibrillation (...
More than 10 percent of patients treated with aspirin therapy for primary cardiovascular disease prevention were likely inappropriately prescribed medication,...
AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with...
DAPT study
Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop...

Video Center

It’s been no secret that the American healthcare system needed to change to survive economically...
3 weeks 19 hours ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
5 weeks 22 hours ago
The America College of Cardiology has released its list of key late-breaking clinical trials at the...
6 weeks 1 day ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available